News
Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat cancers and viruses, ...
Binance transitions from a rogue exchange to a global crypto policy leader, advising governments and shaping crypto regulations worldwide.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results